ATP6AP1 and breast carcinoma: In summary, our study demonstrated that ATP6AP1 accelerates the process of autophagy by facilitating V-ATPase-mediated lysosomal acidification and Rab7-dependent lysosome fusion, therefore promoting cell proliferation and drug resistance in luminal breast cancer cells (Fig.7).